A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence and duration.
作者信息
Alufandika Melanie, Lawrence David S, Boyer-Chammard Timothée, Kanyama Cecilia, Ndhlovu Chiratidzo E, Mosepele Mosepele, Tugume Lillian, Meya David, Boulware David R, Rhein Joshua, Muzoora Conrad, Youssouf Nabila, Molloy Síle F, Schutz Charlotte, Lortholary Olivier, Meintjes Graeme, Mwandumba Henry C, Harrison Thomas S, Jarvis Joseph N
机构信息
Malawi-Liverpool-Wellcome Trust Clinical Research Programme.
African Centre of Excellence in Public Health and Herbal medicine (ACEPHEM), University of Malawi College of Medicine, Blantyre, Malawi.
出版信息
AIDS. 2020 Jul 15;34(9):1425-1428. doi: 10.1097/QAD.0000000000002556.
Abstract
摘要
相似文献
1
A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence and duration.一种管理确诊为HIV相关隐球菌性脑膜炎且有抗逆转录病毒治疗经验患者的实用方法：抗逆转录病毒治疗依从性和疗程的影响
AIDS. 2020 Jul 15;34(9):1425-1428. doi: 10.1097/QAD.0000000000002556.
2
Neuroimaging of HIV-associated cryptococcal meningitis: comparison of magnetic resonance imaging findings in patients with and without immune reconstitution.人类免疫缺陷病毒相关隐球菌性脑膜炎的神经影像学：有或无免疫重建患者的磁共振成像结果比较
Int J STD AIDS. 2016 Feb;27(2):110-7. doi: 10.1177/0956462415574633. Epub 2015 Feb 18.
3
Predictors of outcome in routine care for Cryptococcal meningitis in Western Kenya: lessons for HIV outpatient care in resource-limited settings.肯尼亚西部常规护理中隐球菌性脑膜炎结局的预测因素：对资源有限环境下艾滋病毒门诊护理的启示。
Postgrad Med J. 2013 Feb;89(1048):73-7. doi: 10.1136/postgradmedj-2012-130823. Epub 2012 Oct 30.
4
Antiretroviral roll-out, antifungal roll-back: access to treatment for cryptococcal meningitis.抗逆转录病毒药物推广，抗真菌药物缩减：隐球菌性脑膜炎的治疗可及性
Lancet Infect Dis. 2005 Sep;5(9):530-1. doi: 10.1016/S1473-3099(05)70197-3.
5
Symptomatic relapse of HIV-associated cryptococcal meningitis: recurrent cryptococcal meningitis or Cryptococcus-related immune reconstitution inflammatory syndrome?HIV 相关隐球菌性脑膜炎的症状性复发：复发性隐球菌性脑膜炎还是隐球菌相关免疫重建炎症综合征？
Int J STD AIDS. 2014 Apr;25(5):369-72. doi: 10.1177/0956462413506889. Epub 2013 Oct 9.
6
Cryptococcal meningitis associated with tuberculosis in HIV infected patients.HIV感染患者中与结核病相关的隐球菌性脑膜炎。
Indian J Tuberc. 2013 Jul;60(3):180-3.
7
Cryptococcal meningoencephalitis relapse after an eight-year delay: an interplay of infection and immune reconstitution.隐球菌性脑膜脑炎八年后复发：感染与免疫重建的相互作用
Int J STD AIDS. 2015 Oct;26(12):912-4. doi: 10.1177/0956462414563630. Epub 2014 Dec 12.
8
Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole.在未接受过抗逆转录病毒治疗或有抗逆转录病毒治疗经验的患者中，使用两性霉素B或氟康唑治疗隐球菌性脑膜炎时的真菌负荷、早期杀菌活性及治疗结果。
Clin Infect Dis. 2007 Jul 1;45(1):76-80. doi: 10.1086/518607. Epub 2007 May 25.
9
Cryptococcal meningoencephalitis in HIV/AIDS: when to start antiretroviral therapy?HIV/AIDS患者的隐球菌性脑膜脑炎：何时开始抗逆转录病毒治疗？
Ann Clin Microbiol Antimicrob. 2017 Mar 6;16(1):9. doi: 10.1186/s12941-017-0184-2.
10
Burden of cryptococcal meningitis in Malawi.马拉维隐球菌性脑膜炎的负担
Trop Doct. 2009 Jan;39(1):32-4. doi: 10.1258/td.2008.080011.
引用本文的文献
1
Recent Antiretroviral Therapy Initiation Is Associated With Increased Mortality Risk in HIV-associated Cryptococcal Meningitis: An Analysis of Clinical Trial Data From Africa.近期开始抗逆转录病毒治疗与HIV相关隐球菌性脑膜炎患者死亡风险增加有关：一项来自非洲的临床试验数据分析
Clin Infect Dis. 2025 Aug 1;81(1):75-83. doi: 10.1093/cid/ciae586.
2
Prevalence, treatment, and factors associated with cryptococcal meningitis post introduction of integrase inhibitors antiretroviral based regimens among People Living with HIV in Tanzania.坦桑尼亚 HIV 感染者中整合酶抑制剂抗逆转录病毒方案引入后隐球菌性脑膜炎的流行率、治疗和相关因素。
PLoS One. 2024 Feb 27;19(2):e0294940. doi: 10.1371/journal.pone.0294940. eCollection 2024.
3
Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM.全球隐球菌病诊断和管理指南：欧洲癌症研究与治疗组织和国际系统性真菌感染学会与美国微生物学会合作开展的一项倡议。
Lancet Infect Dis. 2024 Aug;24(8):e495-e512. doi: 10.1016/S1473-3099(23)00731-4. Epub 2024 Feb 9.
4
Cryptococcal meningitis.隐球菌性脑膜炎
Nat Rev Dis Primers. 2023 Nov 9;9(1):62. doi: 10.1038/s41572-023-00472-z.
5
Cryptococcal and Antigen Screening Among People With Human Immunodeficiency Virus in Ghana and Comparative Analysis of OIDx Lateral Flow Assay and IMMY Enzyme Immunoassay.加纳人类免疫缺陷病毒感染者的隐球菌和抗原筛查以及OIDx侧向流动检测法与IMMY酶免疫测定法的比较分析
Open Forum Infect Dis. 2022 Jun 3;9(7):ofac277. doi: 10.1093/ofid/ofac277. eCollection 2022 Jul.
6
High Burden of Cryptococcal Meningitis Among Antiretroviral Therapy-Experienced Human Immunodeficiency Virus-Infected Patients in Northern Uganda in the Era of "Test and Treat": Implications for Cryptococcal Screening Programs.在“检测即治疗”时代，乌干达北部接受抗逆转录病毒治疗的人类免疫缺陷病毒感染患者中隐球菌性脑膜炎负担沉重：对隐球菌筛查项目的启示
Open Forum Infect Dis. 2022 Jan 10;9(2):ofac004. doi: 10.1093/ofid/ofac004. eCollection 2022 Feb.
7
Short-term Mortality Outcomes of HIV-Associated Cryptococcal Meningitis in Antiretroviral Therapy-Naïve and -Experienced Patients in Sub-Saharan Africa.撒哈拉以南非洲地区未接受过抗逆转录病毒治疗和接受过抗逆转录病毒治疗的患者中，与艾滋病毒相关的隐球菌性脑膜炎的短期死亡率结局
Open Forum Infect Dis. 2021 Jul 28;8(10):ofab397. doi: 10.1093/ofid/ofab397. eCollection 2021 Oct.
8
Cryptococcal Immune Reconstitution Inflammatory Syndrome: From Blood and Cerebrospinal Fluid Biomarkers to Treatment Approaches.隐球菌免疫重建炎症综合征：从血液和脑脊液生物标志物到治疗方法
Life (Basel). 2021 Jan 27;11(2):95. doi: 10.3390/life11020095.
本文引用的文献
1
Cryptococcal Antigenemia in Human Immunodeficiency Virus Antiretroviral Therapy-Experienced Ugandans With Virologic Failure.人类免疫缺陷病毒（HIV）抗逆转录病毒治疗后病毒学失败的乌干达患者中隐球菌抗原血症。
Clin Infect Dis. 2020 Oct 23;71(7):1726-1731. doi: 10.1093/cid/ciz1069.
2
One-year Mortality Outcomes From the Advancing Cryptococcal Meningitis Treatment for Africa Trial of Cryptococcal Meningitis Treatment in Malawi.马拉维隐球菌性脑膜炎推进治疗非洲试验的一年期死亡率结果
Clin Infect Dis. 2020 Jan 16;70(3):521-524. doi: 10.1093/cid/ciz454.
3
High Mortality in HIV-Associated Cryptococcal Meningitis Patients Treated With Amphotericin B-Based Therapy Under Routine Care Conditions in Africa.在非洲常规护理条件下接受基于两性霉素B治疗的HIV相关隐球菌性脑膜炎患者的高死亡率
Open Forum Infect Dis. 2018 Oct 23;5(11):ofy267. doi: 10.1093/ofid/ofy267. eCollection 2018 Nov.
4
AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.两性霉素B脂质体治疗诱导优化（AMBITION）：撒哈拉以南非洲地区高剂量两性霉素B脂质体用于隐球菌性脑膜炎诱导治疗：一项3期随机对照非劣效性试验的研究方案
Trials. 2018 Nov 23;19(1):649. doi: 10.1186/s13063-018-3026-4.
5
Detrimental Outcomes of Unmasking Cryptococcal Meningitis With Recent ART Initiation.近期开始抗逆转录病毒治疗后暴露隐球菌性脑膜炎的不良后果。
Open Forum Infect Dis. 2018 May 24;5(8):ofy122. doi: 10.1093/ofid/ofy122. eCollection 2018 Aug.
6
Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis.HIV 阳性合并隐球菌性脑膜炎患者早期与延迟抗逆转录病毒治疗的比较
Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD009012. doi: 10.1002/14651858.CD009012.pub3.
7
Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.抗真菌药物联合治疗非洲隐球菌性脑膜炎。
N Engl J Med. 2018 Mar 15;378(11):1004-1017. doi: 10.1056/NEJMoa1710922.
8
The Continuing Burden of Advanced HIV Disease Over 10 Years of Increasing Antiretroviral Therapy Coverage in South Africa.南非抗逆转录病毒治疗覆盖率持续增加 10 年，艾滋病毒晚期疾病负担持续存在。
Clin Infect Dis. 2018 Mar 4;66(suppl_2):S118-S125. doi: 10.1093/cid/cix1140.
9
Evolving Failures in the Delivery of Human Immunodeficiency Virus Care: Lessons From a Ugandan Meningitis Cohort 2006-2016.人类免疫缺陷病毒护理提供中的不断演变的失败：来自乌干达2006 - 2016年脑膜炎队列的经验教训
Open Forum Infect Dis. 2017 Apr 19;4(2):ofx077. doi: 10.1093/ofid/ofx077. eCollection 2017 Spring.
10
Advanced Human Immunodeficiency Virus Disease in Botswana Following Successful Antiretroviral Therapy Rollout: Incidence of and Temporal Trends in Cryptococcal Meningitis.博茨瓦纳在成功推出抗逆转录病毒疗法后出现的人类免疫缺陷病毒（HIV）晚期疾病：隐球菌性脑膜炎的发病率和时间趋势。
Clin Infect Dis. 2017 Sep 1;65(5):779-786. doi: 10.1093/cid/cix430.
Zotero 插件